IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal/skin microbiota homeostasis and altered microbiota function

IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal/skin microbiota homeostasis and altered microbiota function

BackgroundDisturbed gut microbiota and associated metabolic dysfunction exist in Psoriasis. Despite the growing use of interleukin-17 inhibitor (anti-IL17) therapy, the effect of anti-IL17 on gut/skin microbiota function is not fully understood in patients with Psoriasis.ObjectiveTherefore, we explo...

Full description

Bibliographic Details
Main Authors: Huixia Zhao, Lili Shang, Yuting Zhang, Zhaojun Liang, Nan Wang, Qian Zhang, Chong Gao, Jing Luo
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Immunology
Subjects:
psoriasis
gut microbiome
skin microbiome
gut-skin axis
IL-17A inhibitor
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1344963/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1344963/full

Similar Items